Gelstat Stock

Gelstat AAQS

The The AAQS of Gelstat (GSAC) as of Aug 7, 2026 is 5. In the previous year, The AAQS was 5.00 — a change of 0.00% (lower).

AAQS

5

YoY

0.00%

Last updated:

Gelstat has a current AAQS of 5.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Gelstat in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
Access this data via the Eulerpool API

Gelstat Stock analysis

What does Gelstat do? The Gelstat Corporation is a US-American company specializing in the production of pharmaceuticals and complementary preparations. The development and marketing of products that improve well-being and health is at the center of the company's business model. The Gelstat Corporation was founded in 2004 by Dr. Thomas Smith and Dr. David Knopman. Originally, the company focused on the development of methods for the diagnosis of degenerative brain diseases. In collaboration with renowned research institutions and universities, the Gelstat Corporation was able to achieve valuable achievements in this field. In 2008, the company expanded its portfolio and began producing medications and dietary supplements. The Gelstat Corporation focused particularly on the use of ingredients that have positive effects on the body and well-being according to scientific studies. Currently, the company is divided into two main divisions: Gelstat Migraine and Gelstat Sleep. Gelstat Migraine is an over-the-counter preparation used for pain relief in migraine attacks. The product contains a high concentration of magnesium and therefore does not cause side effects such as nausea or dizziness that can occur with many other pain relievers. The use of Gelstat Migraine in combination with other medications is also safe. Gelstat Sleep is a dietary supplement taken to improve sleep quality. It contains a combination of plant-based ingredients such as valerian, passionflower, and melatonin. These active ingredients have a calming effect and can help to fall asleep and stay asleep more quickly. Gelstat Sleep is free of chemical substances and therefore suitable for long-term use. In addition to the two main divisions, Gelstat Corporation also offers other products based on natural ingredients. These include dietary supplements to strengthen the immune system, products for joint discomfort, and for improving memory performance. The goal of Gelstat Corporation is to promote the health and well-being of people in a natural way. The company ensures that all production steps are carried out under strict quality controls. The product development is also based on scientific studies and done in close collaboration with experts in the respective field. In summary, the Gelstat Corporation is an innovative company specializing in the production of pharmaceuticals and complementary preparations. The company's products are based on natural ingredients and have positive effects on the well-being and health of people. Through close collaboration with experts and strict adherence to quality standards, Gelstat Corporation has quickly made a name for itself in the industry. Gelstat is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gelstat stock

The AAQS of Gelstat is 5 in 2026.

On Eulerpool you can find the complete historical development of The AAQS Gelstat since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

Quality — Gelstat

All Key Metrics — Gelstat